Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BGB-B3227 |
Trade Name | |
Synonyms | BGBB3227|BGB B3227 |
Drug Descriptions |
Limited information is currently available on BGB-B3227, a putative bispecific antibody targeting MUC1 and CD16a (Sep 2024). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BGB-B3227 | BGB-B3227 | 0 | 0 |
BGB-B3227 + Tislelizumab | BGB-B3227 Tislelizumab | 0 | 0 |